ADT, Inc. Stock News

BOCA RATON, Fla., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (“ADT” or the “Company”) today announced the pricing of the previously announced secondary public offering of 56,000,000 shares of the Company's common stock held by certain entities managed by affiliates of Apollo Global Management, Inc. (the “Selling Stockholders”). The offering is expected to close on October 30, 2024, ...

BOCA RATON, Fla., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (“ADT” or the “Company”) today announced a proposed secondary public offering of 56,000,000 shares of the Company's common stock held by certain entities managed by affiliates of Apollo Global Management, Inc. (the “Selling Stockholders”).

ADT Inc. (NYSE:ADT ) Q3 2024 Earnings Call Transcript October 24, 2024 10:00 AM ET Company Participants Elizabeth Landers - Senior Director, Investor Relations Jim DeVries - Chief Executive Officer, President & Chairman Jeff Likosar - Chief Financial Officer Wayne Thorsen - Chief Business Officer Conference Call Participants George Tong - Goldman Sachs David Paige - RBC Toni Kaplan - Morgan Sta...

Continued strong financial results, cash generation, and leverage reduction Revenue up 5% versus prior year period GAAP income from continuing operations up 7%; Adjusted EBITDA up 6% Record-high recurring monthly revenue; solid customer retention On track to achieve full year 2024 guidance metrics BOCA RATON, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), the most trusted brand i...

BOCA RATON, Fla., Oct. 17, 2024 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) will release its third quarter 2024 financial results before the market opens on Thursday, Oct. 24, 2024.

Home security firm ADT Inc said on Monday an unauthorized actor had illegally accessed its network using credentials obtained through a third-party business partner.

I give a buy rating for ADT Inc. due to its leading position and strong partnerships in the growing U.S. home security market. ADT benefits from a large total addressable market, with significant growth potential as many households still lack security solutions. Key partnerships with Google and State Farm enhance distribution capabilities, driving higher ARPU and customer retention.

ORION CORPORATION PRESS RELEASE 16 SEPTEMBER 2024 at 11.30 EEST          Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer Results from the pivotal Phase III ARANOTE trial evaluating darolutamide plus androgen deprivation therapy (ADT...